One in two Americans suffer from musculoskeletal (MSK) pain and over 16 million adults in the United States have at least one major depressive episode in a given year. Researchers have uncovered a phenomenon called the “depression-pain dyad” where chronic pain increases the risk for depression and depression increases the perceived severity of pain.
Given the high comorbidity of depression and MSK pain, health insurance providers and employers are increasingly looking to holistic interventions to break the cycle of member’s physical and mental pain and reduce high MSK spend.
This webinar will explore how chronic musculoskeletal (MSK) pain and depression are connected and why the two conditions need to be addressed together. It will also address why traditional treatment methods have come up short in improving long-term member outcomes. We’ll examine a case study where an employer helped their members reduce MSK pain 4x better than opioids, dramatically cut depression rates, and reduced medical spend by avoiding 2 out of 3 surgeries.
Dr. Jeff Krauss, MD
Chief Medical Officer
Dr. Jeff Krauss is Hinge Health’s Chief Medical Officer. He is currently a Clinical Assistant Professor at Stanford University in the Department of Orthopedics, and continues to practice as a part-time Staff Physician at the VA Palo Alto Health Care System. Jeff graduated from Harvard College, earned his Medical degree from UC San Francisco School of Medicine, and completed his residency in Physical Medicine & Rehabilitation at Stanford University.
As the North American Benefits Manager for IDEXX Laboratories, Debra Tierney manages employee benefits programs for over 6,000 employees. She has been with IDEXX for 20 years in various human resources and benefits related roles. Debra holds a Bachelor of Arts degree in Biology-Environmental Science from Colby College, a Masters of Natural Resources degree from the University of Vermont, and an MBA from the University of Southern Maine.